Scott Terrillion
CIK 1706426 · SEC'Y; CHIEF COMPLIANCE & G.C. · last filed 2025-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
29
Lifetime Open-Market Net
-$566.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics, Inc. (CARA) Delisted | SEC'Y; CHIEF COMPLIANCE & G.C. | 7,190 | $15.96 | $114.8K | -$566.7K | 29 | 2025-03-04 |
Recent Filings · Page 2 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-05 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −1,642 | -$19.6K | EDGAR |
| 2022-03-04 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −1,787 | -$20.3K | EDGAR |
| 2022-03-01 | Tvardi Therapeutics, Inc. (CARA) Delisted | Mixed | +23,361 | -$20.3K | EDGAR |
| 2021-12-21 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +11,495 | $0 | EDGAR |
| 2021-09-01 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −1,759 | -$25.0K | EDGAR |
| 2021-08-26 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +5,334 | $0 | EDGAR |
| 2021-04-01 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +16,000 | $0 | EDGAR |
| 2021-03-08 | Tvardi Therapeutics, Inc. (CARA) Delisted | Mixed | +6,910 | -$55.6K | EDGAR |
| 2021-02-25 | Tvardi Therapeutics, Inc. (CARA) Delisted | Mixed | +1,996 | -$77.4K | EDGAR |
| 2020-12-30 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −1,946 | -$29.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.